Amiloride Hydrochloride

盐酸阿米洛利

Report date: 2023/03/03 09:37:28
NME

Base Information

Drug NameAmiloride Hydrochloride
Drug Alias Name氨氯吡脒Amiloridum盐酸氨氯吡咪amilorida阿米诺利 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityHeartburnEdema +[14] 
Global Approved IndicationsEdemaHypokalemia
Approved Indications in ChinaEdemaHypokalemia
Original Approved Country/TerritoryUnited States
Original Approved Date1981/10/05
Country/TerritoryCanadaUnited StatesAustria +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPerrigo Llc
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityPaddock LlcUniversity Of Missouri +[5] 
Inactive CompaniesSuny Upstate Medical UniversityUniversity Of OxfordThe University Of New Mexico +[5] 
Active IndicationsEdemaOverweightObesity +[5] 
Inactive IndicationsAttention Deficit Disorder with HyperactivityHeartburnDiabetes Mellitus, Type 2 +[9] 

Other Information

ATC CodeC03DB01
Related LinksWikipediaDrugBankKEGG